Conmed Corp.

Conmed Corp.

CNMD

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.07B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Conmed Corp.Conmed Corp.19.91.12%5%0.80.8
$90.90

Current Fair Value

158.8% upside

Undervalued by 158.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.07 Billion
Enterprise Value$1.90 Billion
Dividend Yield$0.40 (1.12%)
Earnings per Share$1.52
Beta0.94
Outstanding Shares30,588,000

Return

Return on Equity5.39%ROE
Return on Assets2.37%
Return on Invested Capital5.66%

Valuation & Multiples

P/E Ratio19.91P/E Ratio
PEG15.42PEG
Price to Sales0.8Price to Sales
Price to Book Ratio1.06Price to Book Ratio
Enterprise Value to Revenue1.39
Enterprise Value to EBIT16.61
Enterprise Value to Net Income34
Total Debt to Enterprise0.45
Debt to Equity0.85Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 6, 2026
EPS Estimate
$0.82
Average shareholder expectation
Revenue Estimate
$310.59 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 29, 2026
EPS Estimate
$1.10
Average shareholder expectation
Revenue Estimate
$337.46 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.3760 37.60%
Total Calls100,000 1718.18%
Total Puts37,600 Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %109.39% 0.37%
Total Invested$1.20B 13.02%
Investors Holding239 26.00%

ESG Score

No data

About Conmed Corp.

CEO: Curt Hartman

Relevant Senate Committees

Joint Committee on Taxation

This committee's analyses and 'revenue estimates' are foundational to tax legislation, directly influencing corporate tax structures, capital investment credits, and overall fiscal policy, which significantly affects Conmed's financial performance.

Finance

This committee's control over taxation, trade, and entitlement spending, particularly Medicare pricing, directly and significantly impacts the profitability, market access, and overall financial health of a medical device manufacturer like Conmed.

Appropriations

This committee directly controls federal spending allocations, which includes budgets for federal healthcare programs (e.g., VA, DoD hospitals) that purchase medical devices. Its decisions directly impact revenue streams from government contracts.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary regulatory body for medical devices. Decisions regarding device approvals, safety standards, and manufacturing oversight are paramount to Conmed's business. Labor laws also impact its operational costs.

Judiciary

Intellectual property protection (patents) is crucial for medical device manufacturers like Conmed. The committee's oversight of antitrust laws also directly impacts potential mergers and acquisitions within the industry.

Veterans' Affairs

Conmed likely supplies medical devices to the Department of Veterans Affairs (VA) hospitals. This committee's funding decisions directly impact government healthcare contractors and procurement for veterans' healthcare.